Health Insurance Appeals Process: Patient Rights and Procedures

Health insurance appeals are formal mechanisms that allow patients and their representatives to challenge coverage denials, claim rejections, and medical necessity determinations made by insurers. This page provides a comprehensive reference to the federal and state regulatory framework governing internal and external appeals, the procedural stages involved, and the rights patients hold under statutes including the Affordable Care Act and the Employee Retirement Income Security Act (ERISA). Understanding these processes is essential for anyone navigating a denied claim, a prior authorization refusal, or a coverage termination decision.

• Definition and Scope
• Core Mechanics or Structure
• Causal Relationships or Drivers
• Classification Boundaries
• Tradeoffs and Tensions
• Common Misconceptions
• Checklist or Steps (Non-Advisory Framing)
• Reference Table or Matrix
• References

Definition and Scope

A health insurance appeal is a formal request submitted to a health plan — or to an independent review organization designated by a regulatory body — asking that an adverse benefit determination be reconsidered. The scope of appeals rights in the United States is defined by a layered system of federal statutes and implementing regulations that apply differently depending on how a health plan is structured.

The Affordable Care Act (ACA), codified at 42 U.S.C. § 300gg-19, established a minimum national standard for internal and external appeals applicable to non-grandfathered individual and group health plans offered in the individual and small-group markets, as well as non-grandfathered employer-sponsored plans subject to ACA market reforms. The implementing regulations, promulgated jointly by the Departments of Health and Human Services (HHS), Labor (DOL), and Treasury, appear at 45 CFR Part 147 and 29 CFR § 2590.715-2719.

ERISA, at 29 U.S.C. § 1133, separately governs appeals in self-funded employer plans and requires that plans provide adequate notice of denials and a reasonable opportunity for review. The DOL's claims procedure regulation at 29 CFR § 2560.503-1 sets the procedural standards for those plans.

Medicare beneficiaries operate under a distinct appeals system administered by the Centers for Medicare & Medicaid Services (CMS), governed by 42 CFR Part 405, Subpart I. Medicaid enrollees have appeal rights under 42 CFR Part 431, Subpart E, with fair hearing procedures administered at the state level. For patients navigating coverage decisions within those programs, Medicaid and Medicare patient advocacy provides additional context on program-specific protections.

Core Mechanics or Structure

The appeals process under ACA-compliant plans operates in two mandatory tiers: an internal appeal and, if the internal appeal fails, an independent external review.

Internal Appeal
The plan's own reviewers examine the adverse benefit determination. Under 29 CFR § 2590.715-2719(b), plans must:

• Notify claimants of adverse determinations within specific timeframes: 72 hours for urgent care claims, 30 days for pre-service non-urgent claims, and 60 days for post-service claims.
• Accept and consider all evidence submitted by the claimant, including treating physician statements and published clinical evidence.
• Ensure that reviewers of the internal appeal were not involved in the original denial and have appropriate clinical expertise for medical necessity denials.
• Provide the claimant with any new evidence or rationale the plan relies upon and allow the claimant to respond before a final internal decision.

External Review
If the internal appeal upholds the denial, enrollees in ACA-compliant plans have the right to request independent external review by an accredited Independent Review Organization (IRO). The Secretary of HHS maintains a list of approved IROs under 45 CFR § 147.138. External reviewers must be accredited by URAC or the Accreditation Association for Ambulatory Health Care (AAAHC). The external reviewer's decision is binding on the plan. Enrollees must file for external review within 4 months of receiving a final internal denial notice, under the federal standard (45 CFR § 147.138(d)).

Plans may not impose a filing fee greater than $25 for external review requests; the cap is set by the NAIC Uniform External Review Model Act, which most states have adopted as the baseline for state-regulated plans.

Causal Relationships or Drivers

Coverage denials that trigger appeals arise from several structural causes. The most frequent is a medical necessity determination — a payer's conclusion that a requested service does not meet the plan's clinical criteria. Payers commonly reference proprietary criteria sets developed by organizations such as MCG Health or InterQual, though federal regulations require that criteria be disclosed upon request.

A second driver is plan exclusions — provisions in the plan document that categorically exclude a service, drug, or device. A third category involves coding and billing disputes, where a claim is denied due to a diagnosis code mismatch or a bundling edit, rather than a coverage determination per se. These distinctions matter because coding disputes are sometimes better routed through medical billing advocacy processes before or alongside a formal appeal.

Prior authorization denials form a fourth and numerically significant category. Denials of prior authorization requests are treated as adverse benefit determinations under federal regulations, triggering full appeal rights. The intersection of prior authorization policy and appeals rights is examined in detail on the prior authorization guidance for patients reference page.

Classification Boundaries

Not all health plans and not all disputes are governed by the same appeals rules.

Plans subject to ACA internal/external review requirements:
- Non-grandfathered individual market plans
- Non-grandfathered small-group and large-group fully-insured plans
- Non-grandfathered self-funded employer plans (subject to DOL oversight)

Plans with distinct or limited appeal frameworks:
- Grandfathered health plans (ACA external review does not apply; ERISA internal claims procedures still apply to self-funded versions)
- Medicare Advantage plans (CMS-administered; 5-level appeals process under 42 CFR Part 422, Subpart M)
- Original Medicare Parts A and B (5-level process ending at Federal District Court)
- Medicaid managed care plans (state fair hearing rights under 42 CFR § 431.220)
- Short-term limited-duration plans (exempt from most ACA market reform requirements; see 45 CFR § 144.103)

Disputes outside the formal appeals process:
Billing disputes with out-of-network providers are generally handled through the No Surprises Act's independent dispute resolution process rather than through plan appeals. Patients with concerns about that mechanism can reference the No Surprises Act patient guide and the independent dispute resolution for patients pages.

Tradeoffs and Tensions

The appeals framework contains several structural tensions that affect outcomes for patients.

Timeliness versus thoroughness. Expedited appeals — available when the standard timeframe could jeopardize life or health — must be decided within 72 hours. That constraint limits the volume of clinical evidence a claimant can assemble and a reviewer can evaluate. Standard appeals allow more documentation time but may delay treatment.

Plan-funded external review. Although IROs are nominally independent, plans fund the external review system through fees. Researchers and patient advocates have raised questions about systemic incentives, though IRO accreditation standards enforced by URAC and AAAHC are designed to insulate reviewers from financial pressure.

ERISA preemption. For self-funded employer plans, ERISA preempts most state-level patient protection laws, including some state external review mandates. This creates a regulatory gap: enrollees in self-funded plans in states with stronger consumer protections may have fewer enforceable rights than enrollees in fully-insured plans. The DOL's Office of Employee Benefits Security enforces ERISA appeals rights for self-funded plans, but remedies available under ERISA § 502(a) are narrower than those available under state insurance law.

Documentation asymmetry. Plans possess the clinical criteria and coverage determination rationale at the moment of denial; the patient assembles a record afterward. Federal regulations at 29 CFR § 2590.715-2719(b)(2)(ii) require plans to provide relevant documents upon request, but retrieval delays can disadvantage claimants in expedited contexts. Patients managing complex diagnosis situations may find the patient rights and responsibilities framework useful background.

Common Misconceptions

Misconception: A denial letter is the final word.
An initial denial is not a final determination. Under federal regulations, it initiates the formal appeals process. Plans are required to include in every denial notice a description of the applicable review procedures and relevant time limits.

Misconception: External review is always optional.
For ACA-compliant non-grandfathered plans, external review is a federally mandated right, not a discretionary plan feature. Plans are prohibited from imposing restrictions that make external review unavailable.

Misconception: Only the patient can file an appeal.
Under 45 CFR § 147.138 and DOL guidance, an authorized representative — including a licensed patient advocate, attorney, or family member with written authorization — may file and pursue appeals on behalf of the enrollee. Authorized representative status must be recognized by the plan.

Misconception: Verbal denials can be appealed.
Only written adverse benefit determinations trigger the formal appeals clock. A verbal statement from a customer service representative is not an adverse benefit determination under regulatory definitions. Patients should always request written documentation of any denial.

Misconception: All clinical evidence is equally weighted.
Accreditation standards direct the evaluation of evidence based on clinical validity. However, plans and reviewers may weigh research-based evidence, clinical guidelines, and treating physician attestations differently. Submitting a treating physician's letter of medical necessity without supporting clinical literature is a frequently documented gap in unsuccessful appeals.

Checklist or Steps (Non-Advisory Framing)

The following steps reflect the procedural sequence established by federal regulations for ACA-compliant plan appeals. This is a reference outline of process stages, not guidance specific to any individual situation.

1. Obtain written denial documentation. The adverse benefit determination notice must include the specific reason for denial, the plan provision relied upon, and the clinical criteria applied (29 CFR § 2590.715-2719(b)(2)(i)).

2. Identify the appeal deadline. Internal appeal deadlines vary: 180 days from denial notice is the federal minimum for post-service claims under 29 CFR § 2560.503-1. Urgent care appeals have a 72-hour decision window after filing.

3. Request the complete claims file. Plans must provide all documents, records, and other information relevant to the claim determination, at no charge, under 29 CFR § 2590.715-2719(b)(2)(ii).

Compile supporting clinical documentation, which includes treating physician statements, relevant clinical guidelines, research-based literature supporting medical necessity, and prior treatment records.

1. Submit the internal appeal in writing. Include the plan member ID, the specific service or claim at issue, the date of service, and all supporting documentation. Retain timestamped copies.

2. Track the internal review deadline. Plans must decide internal appeals within 60 days (post-service), 30 days (pre-service non-urgent), or 72 hours (urgent care), under the ACA implementing regulations.

3. Receive the internal appeal decision in writing. If upheld, the denial notice must state the right to external review and provide IRO contact information.

4. File for external review within 4 months. The federal standard external review filing deadline is 4 months from the date of the final internal denial notice (45 CFR § 147.138(d)(1)(i)).

5. Cooperate with the IRO's information requests. The IRO may request additional documentation from both the plan and the claimant. Response deadlines are set by accreditation standards.

6. Receive the binding external review decision. If the IRO overturns the denial, the plan must implement the decision within the timeframe specified in the applicable regulations. If the denial is upheld, federal court review under ERISA § 502(a) or state insurance department complaint processes remain available depending on plan type. See filing a healthcare complaint for a parallel reference on regulatory complaint mechanisms.

Reference Table or Matrix

DOI = Department of Insurance; QIC = Qualified Independent Contractor; ALJ = Administrative Law Judge; MAC = Medicare Appeals Council.

References

• 42 U.S.C. § 300gg-19 — ACA Internal Claims and Appeals (via U.S. Code)
• 45 CFR Part 147 — Market Reform Rules, HHS (via eCFR)
• 29 CFR § 2590.715-2719 — DOL ACA Appeals Regulation (via eCFR)
• 29 CFR § 2560.503-1 — DOL ERISA Claims Procedure (via eCFR)
• [42 CFR Part 405,